Louis Moore Bacon's IMCR Position Overview
Louis Moore Bacon (via Moore Capital Management, Lp) currently holds 197,308 shares of Immunocore Holdings plc (IMCR) worth $5.95 M, representing 0.12% of the portfolio. First purchased in 2026-Q1, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Louis Moore Bacon has initiated a new position in IMCR, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Louis Moore Bacon's Immunocore Holdings plc (IMCR) Holding Value Over Time
Track share changes against reported price movement
Quarterly Immunocore Holdings plc (IMCR) Trades by Louis Moore Bacon
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +197,308 | New Buy | 197,308 | $30.15 |
Louis Moore Bacon's Immunocore Holdings plc Investment FAQs
Louis Moore Bacon first purchased Immunocore Holdings plc (IMCR) in Q1 2026, acquiring 197,308 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Louis Moore Bacon has held Immunocore Holdings plc (IMCR) for 1 quarters since Q1 2026.
Louis Moore Bacon's largest addition to Immunocore Holdings plc (IMCR) was in Q1 2026, adding 197,308 shares worth $5.95 M.
According to the latest 13F filing for Q1 2026, Louis Moore Bacon's firm, Moore Capital Management, Lp, owns 197,308 shares of Immunocore Holdings plc (IMCR), valued at approximately $5.95 M.
As of the Q1 2026 filing, Immunocore Holdings plc (IMCR) represents approximately 0.12% of Louis Moore Bacon's publicly disclosed stock portfolio, making it one of their key holdings.
Louis Moore Bacon's peak holding in Immunocore Holdings plc (IMCR) was 197,308 shares, as reported at the end of Q1 2026.